Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer
Condition(s):Anal CancerLast Updated:June 6, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Anal CancerLast Updated:June 6, 2018Completed
Condition(s):Breast CancerLast Updated:October 5, 2012Terminated
Condition(s):EpilepsyLast Updated:November 24, 2015Completed
Condition(s):Hepatic EncephalopathyLast Updated:January 9, 2024Terminated
Condition(s):Newly Diagnosed; Advanced Ovarian Cancer; FIGO Stage III-IV; BRCA Mutation; Complete Response; Partial Response; First Line Platinum ChemotherapyLast Updated:February 29, 2024Active, not recruiting
Condition(s):Active Polyarticular Juvenile Idiopathic ArthritisLast Updated:July 12, 2023Completed
Condition(s):Unresectable or Metastatic MelanomaLast Updated:January 10, 2024Active, not recruiting
Condition(s):Major Depressive DisorderLast Updated:August 21, 2019Completed
Condition(s):Hidradenitis SuppurativaLast Updated:September 1, 2016Terminated
Condition(s):Diabetes; Diabetes Mellitus, Type 1Last Updated:June 11, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.